LAXATIVE MAXIMUM STRENGTH- sennosides tablet, sugar coated 
Chain Drug Consortium

----------

Premier Value 44-348

Active ingredient (in each tablet)

Sennosides USP, 25 mg

Purpose

Stimulant laxative

Uses

Warnings

Do not use

laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before use if you have

noticed a sudden change in bowel habits that persists over a period of 2 weeks.

Ask a doctor or pharmacist before use if you are

taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

When using this product,

do not use for a period longer than 1 week.

Stop use and ask a doctor if

rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

adults and children 12 years and over2 tablets once or twice daily
children 6 to under 12 years1 tablet once or twice daily
children under 6 yearsask a doctor

Other information

Inactive ingredients

acacia, calcium carbonate, carnauba wax, corn starch, dibasic calcium phosphate dihydrate, FD&C blue #1 aluminum lake, iron oxide black, magnesium stearate, methylparaben, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, propylene glycol, propylparaben, shellac glaze, silicon dioxide, sodium benzoate, sodium lauryl sulfate, sucrose, talc, titanium dioxide

Questions or comments?

1-800-426-9391

Principal Display Panel

Premier 
Value®

*COMPARE TO THE ACTIVE INGREDIENT IN
ex•lax® MAXIMUM STRENGTH

Maximum Strength
Laxative

Sennosides USP, 25 mg
STIMULANT LAXATIVE

24 Tablets

actual
size

Gentle, Dependable
Constipation Relief

PV
INDEPENDENTLY TESTED
SATISFACTION GUARANTEED

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

*This product is not manufactured or distributed by
GSK Consumer Healthcare S.A., owner of the registered
trademark ex•lax® Maximum Strength.
50844                   REV0419B34808

Distributed By:
Pharmacy Value Alliance, LLC
407 East Lancaster Avenue,
Wayne, PA 19087

If for any reason you are
not satisfied with this product,
please return it to the store
where purchased
for a full refund.

Premier Value 44-348

Premier Value 44-348

LAXATIVE  MAXIMUM STRENGTH
sennosides tablet, sugar coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-739
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES25 mg
Inactive Ingredients
Ingredient NameStrength
ACACIA (UNII: 5C5403N26O)  
CALCIUM CARBONATE (UNII: H0G9379FGK)  
CARNAUBA WAX (UNII: R12CBM0EIZ)  
STARCH, CORN (UNII: O8232NY3SJ)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C BLUE NO. 1 ALUMINUM LAKE (UNII: J9EQA3S2JM)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
SHELLAC (UNII: 46N107B71O)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
SUCROSE (UNII: C151H8M554)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorblueScoreno score
ShapeROUNDSize10mm
FlavorImprint Code 44;348
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-739-042 in 1 CARTON01/02/2003
112 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)01/02/2003
Labeler - Chain Drug Consortium (101668460)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464manufacture(68016-739) , pack(68016-739)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867837manufacture(68016-739) , pack(68016-739)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867894manufacture(68016-739)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.967626305pack(68016-739)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.117025878manufacture(68016-739)

Revised: 12/2023
Document Id: 0890e773-7ab9-4f75-89bc-a6f5444cffa0
Set id: 49ee4e99-5655-47e6-8bc9-e8cb8f60b9d1
Version: 11
Effective Time: 20231213
 
Chain Drug Consortium